PL3325482T3 - Sposoby otrzymywania cytotoksycznych pochodnych benzodiazepiny - Google Patents

Sposoby otrzymywania cytotoksycznych pochodnych benzodiazepiny

Info

Publication number: PL3325482T3
Authority: PL; Poland
Prior art keywords: methods; benzodiazepine derivatives; cytotoxic benzodiazepine; preparing cytotoxic; preparing
Prior art date: 2015-07-21

Application number

PL16745598T

Other languages

English (en)

Inventor

Baudouin GÉRARD

Manami Shizuka

Michael Louis Miller

Richard A. Silva

Original Assignee

Immunogen, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-07-21

Filing date

2016-07-21

Publication date

2021-01-11

2016-07-21 Application filed by Immunogen, Inc. filed Critical Immunogen, Inc.

2021-01-11 Publication of PL3325482T3 publication Critical patent/PL3325482T3/pl

Links

229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 title 1
125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 title 1
231100000433 cytotoxic Toxicity 0.000 title 1
230000001472 cytotoxic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
- C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/188—Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pyridine Compounds (AREA)
Medicinal Preparation (AREA)

PL16745598T 2015-07-21 2016-07-21 Sposoby otrzymywania cytotoksycznych pochodnych benzodiazepiny PL3325482T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201562195023P	2015-07-21	2015-07-21
US201662327973P	2016-04-26	2016-04-26
PCT/US2016/043414 WO2017015502A1 (en)	2015-07-21	2016-07-21	Methods of preparing cytotoxic benzodiazepine derivatives
EP16745598.9A EP3325482B1 (en)	2015-07-21	2016-07-21	Methods of preparing cytotoxic benzodiazepine derivatives

Publications (1)

Publication Number	Publication Date
PL3325482T3 true PL3325482T3 (pl)	2021-01-11

Family

ID=56557925

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL16745598T PL3325482T3 (pl)	2015-07-21	2016-07-21	Sposoby otrzymywania cytotoksycznych pochodnych benzodiazepiny
PL16745961T PL3325483T3 (pl)	2015-07-21	2016-07-21	Sposoby otrzymywania cytotoksycznych pochodnych benzodiazepinowych

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL16745961T PL3325483T3 (pl)	2015-07-21	2016-07-21	Sposoby otrzymywania cytotoksycznych pochodnych benzodiazepinowych

Country Status (23)

Country	Link
US (11)	US9873708B2 (pl)
EP (7)	EP3325485B1 (pl)
JP (8)	JP2018522018A (pl)
KR (5)	KR102660070B1 (pl)
CN (5)	CN108026103B (pl)
AU (7)	AU2016297087B2 (pl)
CA (4)	CA2991326A1 (pl)
CY (2)	CY1122553T1 (pl)
DK (2)	DK3325482T3 (pl)
ES (4)	ES2959741T3 (pl)
HK (1)	HK1252322A1 (pl)
HR (1)	HRP20201479T1 (pl)
HU (1)	HUE051541T2 (pl)
IL (10)	IL283355B (pl)
LT (2)	LT3325483T (pl)
PL (2)	PL3325482T3 (pl)
PT (2)	PT3325482T (pl)
RS (2)	RS59806B1 (pl)
RU (3)	RU2727151C2 (pl)
SG (2)	SG10202009354SA (pl)
SI (2)	SI3325482T1 (pl)
SM (2)	SMT202000506T1 (pl)
WO (3)	WO2017015495A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2018522018A (ja) *	2015-07-21	2018-08-09	イミュノジェン・インコーポレーテッド	細胞毒性ベンゾジアゼピン誘導体の調製方法
KR102378167B1 (ko)	2016-03-22	2022-03-23	에베 그룹 에. 탈너 게엠베하	기판을 결합하기 위한 방법 및 장치
CN118359705A (zh)	2016-10-19	2024-07-19	英温拉公司	抗体构建体
MX2019007019A (es)	2016-12-22	2019-08-16	Univ Degli Studi Magna Graecia Catanzaro	Anticuerpo monoclonal dirigido a un epitope de cd43 sialoglicosilado especifico asociado al cancer.
ES2935346T3 (es)	2017-01-25	2023-03-06	Immunogen Inc	Métodos para preparar derivados de benzodiazepina citotóxicos
IL322895A (en)	2018-06-05	2025-10-01	King S College London	Btnl3/8-targeted constructs for delivery of cargo to the digestive system
MA54228A (fr)	2018-11-12	2021-09-22	Immunogen Inc	Procédés de préparation de dérivés de benzodiazépine cytotoxiques
KR20210099010A (ko) *	2018-11-12	2021-08-11	이뮤노젠 아이엔씨	세포독성 벤조디아제핀 유도체의 제조 방법
KR20220010481A (ko) *	2019-03-29	2022-01-25	이뮤노젠 아이엔씨	비정상 세포 성장의 억제 또는 증식성 질환의 치료를 위한 세포독성 비스-벤조디아제핀 유도체 및 세포결합제와 이의 접합체
AU2023298568A1 (en)	2022-06-30	2025-01-09	Toray Industries, Inc.	Pharmaceutical composition for cancer treatment and/or prevention

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3763183A (en)	1972-07-10	1973-10-02	Sterling Drug Inc	1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines
US3860600A (en)	1972-07-10	1975-01-14	Sterling Drug Inc	Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines
US4678784A (en)	1984-04-11	1987-07-07	Mcneilab, Inc.	Method for the treatment of LHRH diseases and conditions
US5208020A (en)	1989-10-25	1993-05-04	Immunogen Inc.	Cytotoxic agents comprising maytansinoids and their therapeutic use
GB9205051D0 (en)	1992-03-09	1992-04-22	Cancer Res Campaign Tech	Pyrrolobenzodiazepine derivatives,their preparation,and compositions containing them
ES2149768T3 (es)	1992-03-25	2000-11-16	Immunogen Inc	Conjugados de agentes enlazantes de celulas derivados de cc-1065.
GB9818731D0 (en)	1998-08-27	1998-10-21	Univ Portsmouth	Compounds
ATE240334T1 (de)	1998-08-27	2003-05-15	Spirogen Ltd	Pyrrolobenzodiazepine
EP1242401B1 (en)	1999-11-24	2006-12-27	Immunogen, Inc.	Cytotoxic agents comprising taxanes and their therapeutic use
US6548042B2 (en) *	2000-08-07	2003-04-15	Arstad Erik	Bis-phosphonate compounds
UA75093C2 (en) *	2000-10-06	2006-03-15	Dimensional Pharm Inc	Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
US6441163B1 (en)	2001-05-31	2002-08-27	Immunogen, Inc.	Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
US6716821B2 (en)	2001-12-21	2004-04-06	Immunogen Inc.	Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
US6756397B2 (en)	2002-04-05	2004-06-29	Immunogen, Inc.	Prodrugs of CC-1065 analogs
EP1534674A4 (en)	2002-08-02	2007-11-28	Immunogen Inc	CYTOTOXIC AGENTS CONTAINING NEW, EFFECTIVE TAXANES AND THEIR THERAPEUTIC USE
AU2003259163B2 (en)	2002-08-16	2008-07-03	Immunogen, Inc.	Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
ATE413407T1 (de)	2003-03-31	2008-11-15	Council Scient Ind Res	Pyrrolo(2,1-c)(1,4)benzodiazepin-dimere als antitumormittel und verfahren dafür
RU2338747C2 (ru)	2003-03-31	2008-11-20	Каунсил Оф Сайентифик Энд Индастриал Рисерч	ДИМЕРЫ ПИРРОЛО [2, 1-c][1, 4] БЕНЗОДИАЗЕПИНА В КАЧЕСТВЕ ПРОТИВООПУХОЛЕВЫХ СРЕДСТВ И СПОСОБ ИХ ПОЛУЧЕНИЯ
DE60326060D1 (de)	2003-03-31	2009-03-19	Council Scient Ind Res	Nichtvernetzende pyrroloä2,1-cüä1,4übenzodiazepine als potentielle antitumor-agentien und ihre herstellung
RU2314309C2 (ru)	2003-03-31	2008-01-10	Каунсил Оф Сайентифик Энд Индастриал Рисерч	Пирроло [2.1-c][1.4] бензодиазепины, способ их получения и фармацевтическая композиция на их основе
US8088387B2 (en)	2003-10-10	2012-01-03	Immunogen Inc.	Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
US7276497B2 (en)	2003-05-20	2007-10-02	Immunogen Inc.	Cytotoxic agents comprising new maytansinoids
EP1675857B1 (en)	2003-10-22	2011-07-13	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
JP4520411B2 (ja)	2003-12-31	2010-08-04	カウンシルオブサイエンティフィクアンドインダストリアルリサーチ	ピロロ［２，１−ｃ］［１，４］ベンゾジアゼピン・ハイブリッドの調製方法
PL1720881T3 (pl) *	2004-03-01	2013-05-31	Medimmune Ltd	Pochodne 11-hydroksy-5h-pirolo[2,1-c][1,4]benzodiazepin-5-onu jako kluczowe związki pośrednie do otrzymywania C2 podstawionych pirolobenzodiazepin
GB0404578D0 (en)	2004-03-01	2004-04-07	Spirogen Ltd	Pyrrolobenzodiazepines
GB0410725D0 (en)	2004-05-13	2004-06-16	Spirogen Ltd	Pyrrolobenzodiazepine therapeutic agents
GB0412492D0 (en) *	2004-06-04	2004-07-07	Sterix Ltd	Compound
GB0508084D0 (en) *	2005-04-21	2005-06-01	Spirogen Ltd	Pyrrolobenzodiazepines
GB2439881C (en)	2005-04-21	2011-08-10	Spirogen Ltd	Pyrrolobenzodiazepines
WO2007039752A1 (en)	2005-10-05	2007-04-12	Spirogen Limited	Alkyl 4- [4- (5-oxo-2, 3, 5, 11a-tetrahyd0-5h-pyrr0l0 [2, 1-c] [1, 4] benzodiazepine-8-yloxy) -butyrylamino]-1h-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease
WO2007076035A2 (en) *	2005-12-21	2007-07-05	Abbott Laboratories	Anti-viral compounds
SI1813614T1 (sl)	2006-01-25	2012-01-31	Sanofi 174	Citotoksična sredstva, ki obsegajo nove tomajmicinske derivate
WO2007093873A1 (en)	2006-02-13	2007-08-23	Council Of Scientific And Industrial Research	Bis-pyrr0l0[2,l-c] [1, 4] benzodiazepine- anthraquinone conjugates as antitumour agents and a process for the preparation thereof
PL2032606T3 (pl)	2006-05-30	2014-04-30	Genentech Inc	Przeciwciała i immunokoniugaty oraz ich zastosowania
ES2435779T3 (es)	2007-07-19	2013-12-23	Sanofi	Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico
ATE543826T1 (de)	2007-08-01	2012-02-15	Council Scient Ind Res	Als selektive antitumormittel geeignete pyrroloä2,1-cüä1,4übenzodiazepinglycosid-prodru s
JP2011523628A (ja)	2008-04-30	2011-08-18	イミュノジェン・インコーポレーテッド	有効なコンジュゲートおよび親水性リンカー
DK2281006T3 (da)	2008-04-30	2017-11-06	Immunogen Inc	Tværbindingsmidler og anvendelser deraf
GB0819095D0 (en)	2008-10-17	2008-11-26	Spirogen Ltd	Pyrrolobenzodiazepines
GB0822260D0 (en) *	2008-12-05	2009-01-14	Merten Christoph	Assay
US8637558B2 (en) *	2008-12-30	2014-01-28	Industry-Academic Cooperation Foundation, Chosun University	Thiazolidinedione derivative and use thereof
BRPI1008749B8 (pt) *	2009-02-05	2021-05-25	Immunogen Inc	compostos derivados de benzodiazepina, seus conjugados, composição farmacêutica, seu uso e seus processos de preparação
WO2010126551A1 (en)	2009-04-30	2010-11-04	Immunogen, Inc.	Potent conjugates and hydrophilic linkers
US8314250B2 (en) *	2009-11-24	2012-11-20	Hoffmann-La Roche Inc.	Sultam derivatives
JP5721180B2 (ja)	2009-12-08	2015-05-20	国立大学法人岐阜大学	芳香族化合物、並びに、それを用いたオリゴヌクレオチド誘導体合成用修飾担体、オリゴヌクレオチド誘導体及びオリゴヌクレオチド構築物
US8962279B2 (en) *	2009-12-30	2015-02-24	Intel Corporation	Solid-phase chelators and electronic biosensors
HUE042011T2 (hu) *	2010-02-11	2019-06-28	Celgene Corp	Arilmetoxi-izoindolin-származékok, azok készítményei és alkalmazási módszereik
KR20230044026A (ko)	2010-02-24	2023-03-31	이뮤노젠 아이엔씨	엽산염 수용체 1 항체와 면역접합체 및 이들의 용도
WO2011130613A1 (en) *	2010-04-15	2011-10-20	Seattle Genetics, Inc.	Targeted pyrrolobenzodiazapine conjugates
KR101687054B1 (ko)	2010-04-15	2016-12-15	메디뮨 리미티드	증식성 질환 치료용 피롤로벤조디아제핀
PH12012501836A1 (en)	2010-04-15	2013-02-04	Medimmune Ltd	Pyrrolobenzodiazepines and conjugates thereof
UA120696C2 (uk)	2011-02-15	2020-01-27	Імуноген, Інк.	Спосіб одержання кон'югатів
CN102234253B (zh) *	2011-06-02	2013-07-03	重庆莱美药业股份有限公司	一种制备非布索坦中间体的方法
HK1211208A1 (zh)	2012-08-22	2016-05-20	Immunogen, Inc.	細胞毒性苯並二氮呯衍生物
WO2015051045A2 (en)	2013-10-04	2015-04-09	Novartis Ag	3'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE
CN104628772A (zh) *	2013-11-07	2015-05-20	四川恒康发展有限责任公司	一种抗肿瘤前药及其激活剂、组合物和应用
CN103664896B (zh) *	2013-11-25	2016-03-02	济南精合医药科技有限公司	一种抗肿瘤分子靶向药物克里唑替尼的合成工艺方法
TW201609152A (zh)	2014-09-03	2016-03-16	免疫原公司	包含細胞結合劑及細胞毒性劑之偶聯物
TW201613930A (en)	2014-09-03	2016-04-16	Immunogen Inc	Cytotoxic benzodiazepine derivatives
SG11201701455SA (en)	2014-09-03	2017-03-30	Immunogen Inc	Cytotoxic benzodiazepine derivatives
JP2018522018A (ja) *	2015-07-21	2018-08-09	イミュノジェン・インコーポレーテッド	細胞毒性ベンゾジアゼピン誘導体の調製方法
FI3380525T3 (fi) *	2015-11-25	2024-01-30	Immunogen Inc	Lääkeformulaatioita ja niiden käyttömenetelmiä

2016
- 2016-07-21 JP JP2018502800A patent/JP2018522018A/ja not_active Withdrawn
- 2016-07-21 WO PCT/US2016/043402 patent/WO2017015495A1/en not_active Ceased
- 2016-07-21 EP EP16748205.8A patent/EP3325485B1/en active Active
- 2016-07-21 JP JP2018502791A patent/JP6787995B2/ja not_active Expired - Fee Related
- 2016-07-21 ES ES20181645T patent/ES2959741T3/es active Active
- 2016-07-21 IL IL283355A patent/IL283355B/en unknown
- 2016-07-21 CN CN201680053093.1A patent/CN108026103B/zh not_active Expired - Fee Related
- 2016-07-21 EP EP22195446.4A patent/EP4163284A1/en not_active Withdrawn
- 2016-07-21 SI SI201630923T patent/SI3325482T1/sl unknown
- 2016-07-21 IL IL286788A patent/IL286788B2/en unknown
- 2016-07-21 DK DK16745598.9T patent/DK3325482T3/da active
- 2016-07-21 EP EP16745961.9A patent/EP3325483B1/en active Active
- 2016-07-21 RS RS20191647A patent/RS59806B1/sr unknown
- 2016-07-21 EP EP16745598.9A patent/EP3325482B1/en active Active
- 2016-07-21 PT PT167455989T patent/PT3325482T/pt unknown
- 2016-07-21 SI SI201630578T patent/SI3325483T1/sl unknown
- 2016-07-21 US US15/216,512 patent/US9873708B2/en active Active
- 2016-07-21 EP EP19200626.0A patent/EP3653628B1/en active Active
- 2016-07-21 US US15/216,517 patent/US9890179B2/en not_active Expired - Fee Related
- 2016-07-21 KR KR1020187005041A patent/KR102660070B1/ko active Active
- 2016-07-21 LT LTEP16745961.9T patent/LT3325483T/lt unknown
- 2016-07-21 CA CA2991326A patent/CA2991326A1/en not_active Abandoned
- 2016-07-21 CA CA2991305A patent/CA2991305C/en active Active
- 2016-07-21 CN CN202110366892.7A patent/CN113087763A/zh active Pending
- 2016-07-21 HU HUE16745598A patent/HUE051541T2/hu unknown
- 2016-07-21 PT PT167459619T patent/PT3325483T/pt unknown
- 2016-07-21 AU AU2016297087A patent/AU2016297087B2/en not_active Ceased
- 2016-07-21 ES ES16745961T patent/ES2764548T3/es active Active
- 2016-07-21 AU AU2016297608A patent/AU2016297608B2/en not_active Ceased
- 2016-07-21 HK HK18111602.7A patent/HK1252322A1/zh unknown
- 2016-07-21 IL IL294651A patent/IL294651B2/en unknown
- 2016-07-21 KR KR1020187003181A patent/KR102659706B1/ko active Active
- 2016-07-21 ES ES16745598T patent/ES2820358T3/es active Active
- 2016-07-21 SG SG10202009354SA patent/SG10202009354SA/en unknown
- 2016-07-21 IL IL305279A patent/IL305279A/en unknown
- 2016-07-21 SM SM20200506T patent/SMT202000506T1/it unknown
- 2016-07-21 DK DK16745961.9T patent/DK3325483T3/da active
- 2016-07-21 WO PCT/US2016/043414 patent/WO2017015502A1/en not_active Ceased
- 2016-07-21 WO PCT/US2016/043406 patent/WO2017015496A1/en not_active Ceased
- 2016-07-21 HR HRP20201479TT patent/HRP20201479T1/hr unknown
- 2016-07-21 KR KR1020187005040A patent/KR20180038460A/ko not_active Withdrawn
- 2016-07-21 EP EP23183947.3A patent/EP4286387A3/en not_active Withdrawn
- 2016-07-21 IL IL305989A patent/IL305989A/en unknown
- 2016-07-21 CN CN201680053120.5A patent/CN108055844A/zh active Pending
- 2016-07-21 KR KR1020247012816A patent/KR20240055894A/ko not_active Withdrawn
- 2016-07-21 SG SG10202106529XA patent/SG10202106529XA/en unknown
- 2016-07-21 CA CA3227588A patent/CA3227588A1/en active Pending
- 2016-07-21 KR KR1020247012991A patent/KR20240055903A/ko not_active Withdrawn
- 2016-07-21 JP JP2018502785A patent/JP6858745B2/ja not_active Expired - Fee Related
- 2016-07-21 RU RU2018105756A patent/RU2727151C2/ru active
- 2016-07-21 CN CN201680051138.1A patent/CN108290895B/zh not_active Expired - Fee Related
- 2016-07-21 US US15/216,548 patent/US10081640B2/en active Active
- 2016-07-21 LT LTEP16745598.9T patent/LT3325482T/lt unknown
- 2016-07-21 PL PL16745598T patent/PL3325482T3/pl unknown
- 2016-07-21 EP EP20181645.1A patent/EP3778602B1/en active Active
- 2016-07-21 AU AU2016297607A patent/AU2016297607A1/en not_active Abandoned
- 2016-07-21 CN CN202110219412.4A patent/CN113004288A/zh active Pending
- 2016-07-21 RS RS20201132A patent/RS60840B1/sr unknown
- 2016-07-21 SM SM20200004T patent/SMT202000004T1/it unknown
- 2016-07-21 CA CA2992082A patent/CA2992082A1/en active Pending
- 2016-07-21 ES ES19200626T patent/ES2933376T3/es active Active
- 2016-07-21 PL PL16745961T patent/PL3325483T3/pl unknown
- 2016-07-21 RU RU2018105752A patent/RU2018105752A/ru not_active Application Discontinuation
- 2016-07-21 RU RU2018105609A patent/RU2746322C2/ru active
2017
- 2017-12-11 US US15/837,832 patent/US10370389B2/en active Active
2018
- 2018-01-03 US US15/860,864 patent/US10392407B2/en not_active Expired - Fee Related
- 2018-01-11 IL IL256854A patent/IL256854A/en unknown
- 2018-01-11 IL IL256860A patent/IL256860B/en active IP Right Grant
- 2018-01-11 IL IL256861A patent/IL256861B/en active IP Right Grant
- 2018-09-12 US US16/129,008 patent/US10899775B2/en active Active
2019
- 2019-06-06 US US16/433,117 patent/US10787463B2/en active Active
- 2019-06-21 US US16/448,261 patent/US20200017526A1/en not_active Abandoned
- 2019-12-30 CY CY20191101364T patent/CY1122553T1/el unknown
2020
- 2020-08-10 IL IL276631A patent/IL276631B/en unknown
- 2020-08-10 IL IL276630A patent/IL276630B/en active IP Right Grant
- 2020-08-12 US US16/991,700 patent/US11420982B2/en active Active
- 2020-09-23 CY CY20201100899T patent/CY1123390T1/el unknown
- 2020-10-28 JP JP2020180147A patent/JP6995178B2/ja not_active Expired - Fee Related
- 2020-11-23 US US17/101,942 patent/US20210171547A1/en not_active Abandoned
2021
- 2021-03-24 JP JP2021049502A patent/JP7337114B2/ja active Active
- 2021-04-20 AU AU2021202403A patent/AU2021202403B2/en not_active Ceased
- 2021-05-17 AU AU2021203148A patent/AU2021203148B2/en not_active Ceased
- 2021-12-14 JP JP2021202215A patent/JP7334228B2/ja active Active
2022
- 2022-12-14 US US18/080,973 patent/US20230257400A1/en not_active Abandoned
2023
- 2023-03-03 AU AU2023201339A patent/AU2023201339A1/en not_active Abandoned
- 2023-04-11 AU AU2023202221A patent/AU2023202221A1/en not_active Abandoned
- 2023-08-16 JP JP2023132536A patent/JP2023162264A/ja not_active Withdrawn
- 2023-08-22 JP JP2023134420A patent/JP2023166434A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
US9890179B2 (en)	2018-02-13
AU2021202403B2 (en)	2022-12-08
SG10202009354SA (en)	2020-11-27
RU2018105609A (ru)	2019-08-26
CA3227588A1 (en)	2017-01-26
KR20240055903A (ko)	2024-04-29
IL286788B1 (en)	2023-09-01
SMT202000004T1 (it)	2020-03-13
EP3325482A1 (en)	2018-05-30
EP3325482B1 (en)	2020-06-24
HUE051541T2 (hu)	2021-03-01
HRP20201479T1 (hr)	2020-12-11
US10787463B2 (en)	2020-09-29
US20210171547A1 (en)	2021-06-10
HK1252322A1 (zh)	2019-05-24
EP3325483A1 (en)	2018-05-30
EP3325485B1 (en)	2020-04-08
LT3325482T (lt)	2020-11-25
JP2021100959A (ja)	2021-07-08
IL276631B (en)	2021-10-31
US20210171546A1 (en)	2021-06-10
RS59806B1 (sr)	2020-02-28
HK1252321A1 (en)	2019-05-24
IL286788A (en)	2021-10-31
JP2018522018A (ja)	2018-08-09
CA2991326A1 (en)	2017-01-26
IL256860B (en)	2020-08-31
EP3778602B1 (en)	2023-07-12
EP3325485A1 (en)	2018-05-30
KR20180026741A (ko)	2018-03-13
EP3325483B1 (en)	2019-10-02
AU2016297608B2 (en)	2021-02-18
US10899775B2 (en)	2021-01-26
JP7334228B2 (ja)	2023-08-28
AU2021203148A1 (en)	2021-06-10
US20190112320A1 (en)	2019-04-18
US20180201626A1 (en)	2018-07-19
IL305989A (en)	2023-11-01
KR102659706B1 (ko)	2024-04-23
US9873708B2 (en)	2018-01-23
IL294651B1 (en)	2023-10-01
IL256861A (en)	2018-03-29
US20170050986A1 (en)	2017-02-23
AU2016297607A1 (en)	2018-02-08
ES2764548T3 (es)	2020-06-03
ES2933376T3 (es)	2023-02-06
LT3325483T (lt)	2020-01-27
JP7337114B2 (ja)	2023-09-01
US20170050985A1 (en)	2017-02-23
AU2023201339A1 (en)	2023-04-06
EP4163284A1 (en)	2023-04-12
AU2016297087A1 (en)	2018-02-08
KR20180038460A (ko)	2018-04-16
PT3325483T (pt)	2020-01-15
IL276630A (en)	2020-09-30
EP3653628A1 (en)	2020-05-20
CN108290895B (zh)	2021-03-19
JP2022046542A (ja)	2022-03-23
US10081640B2 (en)	2018-09-25
IL283355A (en)	2021-07-29
US20230257400A1 (en)	2023-08-17
CN108290895A (zh)	2018-07-17
US20190389883A1 (en)	2019-12-26
RS60840B1 (sr)	2020-10-30
WO2017015496A1 (en)	2017-01-26
CN113004288A (zh)	2021-06-22
US11420982B2 (en)	2022-08-23
DK3325482T3 (da)	2020-09-28
EP4286387A2 (en)	2023-12-06
PT3325482T (pt)	2020-09-24
AU2021202403A1 (en)	2021-05-20
IL256854A (en)	2018-03-29
ES2959741T3 (es)	2024-02-28
JP2018526340A (ja)	2018-09-13
IL283355B (en)	2022-08-01
EP3778602A1 (en)	2021-02-17
JP6858745B2 (ja)	2021-04-14
KR102660070B1 (ko)	2024-04-24
RU2018105756A3 (pl)	2019-12-23
RU2746322C2 (ru)	2021-04-12
EP4286387A3 (en)	2024-02-21
IL294651A (en)	2022-09-01
US10392407B2 (en)	2019-08-27
US20200017526A1 (en)	2020-01-16
IL256860A (en)	2018-03-29
IL305279A (en)	2023-10-01
DK3325483T3 (da)	2020-01-20
US10370389B2 (en)	2019-08-06
US20190010169A1 (en)	2019-01-10
CN108026103B (zh)	2021-04-16
SG10202106529XA (en)	2021-07-29
CN113087763A (zh)	2021-07-09
RU2018105752A (ru)	2019-08-21
WO2017015495A1 (en)	2017-01-26
JP2023166434A (ja)	2023-11-21
US20170051011A1 (en)	2017-02-23
AU2021203148B2 (en)	2023-01-12
CA2991305C (en)	2024-03-12
JP6787995B2 (ja)	2020-11-18
RU2018105609A3 (pl)	2020-04-30
WO2017015502A1 (en)	2017-01-26
EP3653628B1 (en)	2022-09-14
HK1252323A1 (en)	2019-05-24
AU2016297087B2 (en)	2021-02-18
JP2021035958A (ja)	2021-03-04
PL3325483T3 (pl)	2020-05-18
KR20180038461A (ko)	2018-04-16
CN108026103A (zh)	2018-05-11
CA2991305A1 (en)	2017-01-26
IL294651B2 (en)	2024-02-01
IL286788B2 (en)	2024-01-01
IL256861B (en)	2020-08-31
SMT202000506T1 (it)	2020-11-10
CN108055844A (zh)	2018-05-18
JP6995178B2 (ja)	2022-02-21
CA2992082A1 (en)	2017-01-26
KR20240055894A (ko)	2024-04-29
JP2018524387A (ja)	2018-08-30
JP2023162264A (ja)	2023-11-08
SI3325482T1 (sl)	2020-11-30
CY1122553T1 (el)	2021-01-27
CY1123390T1 (el)	2022-03-24
ES2820358T3 (es)	2021-04-20
AU2016297608A1 (en)	2018-02-08
RU2018105756A (ru)	2019-08-21
RU2727151C2 (ru)	2020-07-21
AU2023202221A1 (en)	2023-05-04
SI3325483T1 (sl)	2020-03-31
RU2018105752A3 (pl)	2019-12-30
WO2017015502A8 (en)	2017-03-02
IL276630B (en)	2021-06-30
IL276631A (en)	2020-09-30

Publication	Publication Date	Title
IL291598A (en)	2022-05-01	History of benzodiazepine cytotoxicity
IL286788A (en)	2021-10-31	Methods for the preparation of cytotoxic benzodiazepine compounds
SG11201706729SA (en)	2017-09-28	Derivatives of sobetirome
HUE056357T2 (hu)	2022-02-28	Szobetirom származékok
IL287405A (en)	2021-12-01	Methods for preparing cytotoxic benzodiazepine derivatives
IL293192A (en)	2022-07-01	Methods for the preparation of indolinobenzodiazepine derivatives
IL283045A (en)	2021-06-30	Methods for preparing cytotoxic benzodiazepine derivatives
IL283047A (en)	2021-06-30	Methods for preparing cytotoxic benzodiazepine derivatives
GB201414116D0 (en)	2014-09-24	Benzodiazepine derivatives
GB201513979D0 (en)	2015-09-23	Synthesis of benzodiazepine derivatives
HUP1400545A2 (hu)	2016-05-30	Eljárás benzazepin származékok elõállítására
HK1236934A1 (zh)	2018-04-06	细胞毒性苯并二氮呯衍生物